National Pharmaceutical Pricing Authority

Type: Organization

Name: National Pharmaceutical Pricing Authority

First reported May 21 2013 - Updated May 21 2013 - 1 reports

NPPA to conduct pre bid meeting on June 3 or 4

Targets to launch SMS-based service for generic/branded medicines before the year endUsha Sharma– MumbaiNational Pharmaceutical Pricing Authority (NPPA) will conduct a pre-bid meeting for the implementation of SMS-based service for generic/branded medicines ... [Published Express Pharma - May 21 2013]

Entities: Drugs, C. P. Singh, National Pharmaceutical Pricing Authority

First reported May 18 2013 - Updated May 18 2013 - 1 reports

Move to rein in prices of medicines

Prices of 348 essential medicines will come down in the state, thanks to a new drug price control order by the Department of Pharmaceuticals.Sources say the prices of these drugs will be reduced by as much as 10-20 per cent, once the new pricing plan ... [Published New Indian Express - May 18 2013]

Entities: National List, Drugs, Price Control, National Pharmaceutical Pricing Authority

First reported May 17 2013 - Updated May 17 2013 - 3 reports

Essential drug prices set to fall by up to 80%

With the government issuing the long-pending Drug Price Control Order (DPCO), prices of 348 essential drugs are expected to reduce by up to 80% in case of life-saving ones and on an average by 20-25% in general. The government on May 16 notified DPCO ... [Published Indian-Commodity - May 17 2013]

Entities: Drugs, Price Control, National Pharmaceutical Pricing Authority, National Pharmaceutical Industries Co SAOG

First reported May 16 2013 - Updated May 16 2013 - 1 reports

NPPA still looking for partners to roll out SMS helpline for consumers

The National Pharmaceutical Pricing Authority (NPPA) is still scouting for the partners to roll out the ambitious project of SMS-based helpline through which the consumers will be able to choose the cheapest brand of a drug prescribed by doctors.The agency, ... [Published PharmaBiz - May 16 2013]

Entities: Drugs, National Pharmaceutical Pricing Authority, Terms of Reference, Information System, Government of India

First reported May 13 2013 - Updated May 13 2013 - 2 reports

India Plans National Source Of Prices For Same Drugs

India is readying a national service to list pharmaceuticals available on the market along with their prices, calling it a short messaging service to be monitored by the National Pharmaceutical Pricing Authority. ... [Published The Rose Sheet - May 13 2013]

Entities: India, Drugs, National Pharmaceutical Pricing Authority

First reported May 10 2013 - Updated May 10 2013 - 2 reports

Three MNCs Denied India Price Increases For Eye, Diabetes Products

Allergan, Novartis and Sanofi have been denied India permission to increase the prices of certain imported drugs on grounds they failed to persuade the National Pharmaceutical Pricing Authority they were justified. ... [Published The Rose Sheet - May 10 2013]

Entities: Rising Prices, Diabetes, India

First reported May 09 2013 - Updated May 09 2013 - 1 reports

Allergan Inc

NPPA denies price hike to Sanofi, Novartis, Allergan

Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has denied a price hike to Sanofi, Novartis, and Allergan for some of their imported products. ... [Published Business Standard India - May 09 2013]

Entities: Allergan Inc, Sanofi SA, Novartis AG

First reported May 07 2013 - Updated May 07 2013 - 1 reports

NPPA hikes price of anti-malarial drug chloroquine, revises prices of 42 formulation packs

The National Pharmaceutical Pricing Authority (NPPA) has increased the price of chloroquine phosphate, the most widely used drug against malaria, and also revised the prices of 42 formulation packs.The price of chloroquine phosphate has been increased ... [Published PharmaBiz - May 07 2013]

Entities: Chloroquine, Chloroquine Phosphate, National Pharmaceutical Pricing Authority, Drugs, dexamethasone

First reported May 04 2013 - Updated May 04 2013 - 1 reports

Drug control department intensifies inspection

In an initiative to check Drug Price Control Order (DPCO) violation, the Kerala Drugs Control Department has intensified inspection in all the retail shops in Ernakulam region. The Ernakulam region of the Drugs Control Department covers Ernakulam, Alappuzha ... [Published New Indian Express - May 04 2013]

Entities: Drugs, National Pharmaceutical Pricing Authority, Manufacturing, Idukki (India), Alappuzha (India)

First reported Apr 22 2013 - Updated Apr 23 2013 - 1 reports

Nifty scales 5800; sixteen stocks in action

NEW DELHI: The 50-share Nifty index scaled its key psychological level of 5,800 in morning trade on Monday, led by gains in banks, metals, auto and capital goods on the back of supportive cues from global peers.According to analysts, shares of banks will ... [Published Economic Times - Apr 22 2013]

Entities: CRISIL Limited, Cipla Ltd, Net Profit, Wipro Ltd

First reported Apr 19 2013 - Updated Apr 19 2013 - 1 reports

Top eight stocks likely to be in focus on Monday

NEW DELHI: Markets closed with gains of nearly 300 points on Thursday buoyed by rate cut hopes and fall in commodity prices, which turned investors' sentiment bullish.The benchmark S&P BSE Sensex regained 19,000 levels for first time since April 2, led ... [Published Economic Times - Apr 19 2013]

Entities: Net Profit, Environment, MRF Ltd, Commodities, National Pharmaceutical Pricing Authority

First reported Mar 06 2013 - Updated Mar 06 2013 - 2 reports

PRICING OF PATETED DRUGS

Last week, the Department of Pharmaceuticals came out with a draft policy on pricing of patented drugs in an attempt to regulate these highly-priced drugs in the country. The Department’s move comes in the wake of submission of the report by the Committee ... [Published PharmaBiz - Mar 06 2013]

Entities: Drugs, Patent, Natco Pharma Limited, Price Control

Quotes

To give some background: In 1988 Indira Gandhi is quoted saying: "The idea of a better-ordered world is one in which medical discoveries will be freefree of patents and there will be no profiteering from life and death!" Yet not everyone, particularly patent owners, agrees...

Innovation Gap [Published Businessworld India - May 23 2013]

The medicines, prices of which will go down, currently have a turnover of ` "29,000 crore per year which amounts to about 60 per cent of the total domestic market. The new order will lead to 40 to 75 per cent reduction in the cost of drugs for cardiovascular, cancer treatment and kidney ailment."

Prices of 348 drugs to come down drastically from May 15 [Published New Indian Express - May 17 2013]

More From BioPortfolio on "Three MNCs Denied India Price Increases For Eye, Diabetes Products"

Three MNCs Denied India Price Increases For Eye, Diabetes Products [Published BioPortfolio - May 10 2013]

"The Nifty is now expected to head higher till 5800. In this period the key support will be around 5701 and resistance will be at 5800" said Somil Mehta, Senior Tech Analyst (Equity) at Sharekhan

Nifty scales 5800; sixteen stocks in action [Published Economic Times - Apr 22 2013]

More Content

sort by: Date \| Relevance
Innovation Gap [Published Businessworld India - May 23 2013]
NEW DPCO & ENFORCEMENT [Published PharmaBiz - May 22 2013]
NPPA to conduct pre bid meeting on June 3 or 4 [Published Express Pharma - May 21 2013]
NPPA to start announcing revised prices of esse... [Published PharmaBiz - May 20 2013]
Move to rein in prices of medicines [Published New Indian Express - May 18 2013]
Essential drug prices set to fall by up to 80% [Published Indian-Commodity - May 17 2013]
Indian essential drug prices to fall "up to 80%" [Published Pharma Times - May 17 2013]
Prices of 348 drugs to come down drastically fr... [Published New Indian Express - May 17 2013]
NPPA still looking for partners to roll out SMS... [Published PharmaBiz - May 16 2013]
Dept of Consumer Affairs backs out from sharing... [Published PharmaBiz - May 14 2013]
India Plans National Source Of Prices For Same ... [Published The Rose Sheet - May 13 2013]
India Plans National Source Of Prices For Same ... [Published BioPortfolio - May 13 2013]
Three MNCs Denied India Price Increases For Eye... [Published The Rose Sheet - May 10 2013]
Three MNCs Denied India Price Increases For Eye... [Published BioPortfolio - May 10 2013]
NPPA denies price hike to Sanofi, Novartis, All... [Published Smart Investor - May 09 2013]
NPPA denies price hike to Sanofi, Novartis, All... [Published Business Standard India - May 09 2013]
NPPA hikes price of anti-malarial drug chloroqu... [Published PharmaBiz - May 07 2013]
Drug control department intensifies inspection [Published New Indian Express - May 04 2013]
Access to medicines: Beyond 2Ps [Published Express Pharma - May 01 2013]
AICDF plans to approach CCI against non-supply ... [Published PharmaBiz - Apr 30 2013]
Nifty scales 5800; sixteen stocks in action [Published Economic Times - Apr 22 2013]
Top eight stocks likely to be in focus on Monday [Published Economic Times - Apr 19 2013]
DoP rejects review petitions filed by Cipla and... [Published PharmaBiz - Apr 18 2013]
Regulator cracksdown on drug prices [Published Hindustan Times - Apr 15 2013]
NPPA to recover Rs.2607.28 cr from several cos ... [Published PharmaBiz - Apr 15 2013]
Court cases, lack of control over launch prices... [Published PharmaBiz - Mar 21 2013]
DoP asks NPPA to review prices fixed for Eli Li... [Published PharmaBiz - Mar 11 2013]
PRICING OF PATETED DRUGS [Published PharmaBiz - Mar 06 2013]
DPCO not to disturb existing norms on price con... [Published PharmaBiz - Mar 06 2013]
Lesser budget allocation puts question mark on ... [Published PharmaBiz - Mar 04 2013]